Intangible Assets

3 Months Ended

Sep. 30, 2011

Intangible Assets

Intangible Assets

8.         Intangible Assets

Intangible assets as of September 30, 2011 and June 30, 2011 consisted of the following (in thousands):

	September 30, 2011			June 30, 2011
	Carrying Value	Accumulated Amortization	Net Carrying Value	Carrying Value	Accumulated Amortization	Net Carrying Value
Prostiva Acquisition
Patents and            Technology	$1,529	($14)	$1,515	-	-	-
Customer Base	531	(5)	526	-	-	-
Trademarks	325	(1)	324	-	-	-
EDAP Acquisition
Customer Base	2,300	(2,228)	72	2,300	(2,221)	79
Other	24	(1)	23	24	(1)	23
Total intangible assets	$ 4,709	($2,249)	$   2,460	$2,324	($2,222)	$102

Amortization expense associated with intangible assets for the three-month periods ended September 30, 2011 and 2010 was $27,000 and $6,000 respectively. Amortization expense increased compared to prior year due to the acquisition of the Prostiva RF Therapy System on September 6, 2011. Please refer to Note 4 of the Condensed Financial Statements for further information regarding this acquisition. All intangible assets are amortized using the straight-line method over their estimated remaining useful lives. Patents and technology, customer base and trademarks related to the Prostiva acquisition are being amortized over 9 years, 9 years, and 16 years, respectively. The customer base related to the EDAP acquisition is being amortized over its remaining useful life of 3 years, and other intangible assets related to patent costs are amortized upon issuance over their estimated useful lives.

Future amortization expense related to the net carrying amount of intangible assets is estimated to be as follows (in thousands):

Fiscal Years
2012	$         234
2013	276
2014	276
2015	258
2016	252